期刊文献+

丙二酰二醛修饰的低密度脂蛋白与冠心病的相关性研究 被引量:3

The relationship between malondialdehyde-modified low-density lipoprotein and coronary heart disease
原文传递
导出
摘要 目的探讨丙二酰二醛修饰的低密度脂蛋白(MDALDL)与冠心病及其他血脂之间的关系。方法选择冠心病患者组68例,正常对照组74名。采用酶联免疫吸附分析(ELISA)的方法检测人血清中MDALDL,同时对受检者的血脂水平进行检测,结果进行统计学分析。结果冠心病患者血清氧化低密度脂蛋白(oxLDL)水平为(115.62±53.4)U/L,明显高于正常对照组(86.7±27.6)U/L(P<0.05);MDALDL与低密度脂蛋白胆固醇(LDLC)水平的比值在冠心病患者组为(43.25±2.64)mmol/U,明显高于正常对照组(33.74±1.58)mmol/U(P<0.01)。血清总胆固醇(TG)、LDLC与MDALDL水平呈显著正相关,相关系数r=0.486,而高密度脂蛋白胆固醇(HDLC)与MDALDL水平呈负相关,相关系数r=0.402。结论MDALDL与冠心病有着非常密切的关系,参与冠心病的发生发展过程。 Objective To investigate the correlation between blood lipids like malondialdehydemodified low-density lipoprotein (MDA-LDL) and coronary heart disease. Methods 68 coronary heart disease patients plus 74 healthy controls were randomly chosen, and ELISA was used to determine serum MDA-LDL levels. Blood lipid levels were also determined. All results were subjected to statistical analysis. Resets Ox-LDL were significantly higher in coronary heart disease group( 115.62 ± 53.4) U/L than in healthy controls ( 86.7 ± 27.6 ) U/L ( P 〈 0.05 ) ; the ratio of MDA-LDL to LDL-C were also significantly higher in coronary heart disease group (43.25 ±2. 64 ) mmol/U than in healthy controls (33.74 ± 1.58) mmol/U, ( P 〈 0. 01 ). TG, LDL-C and MDA-LDL were positively correlated, related coeffcient r=0.486, while HDL-C and MDA-LDL were inversely correlated, related coefficient r = 0. 402.Conclusion MDA-LDL were correlated with coronary heart disease, and may take part in the pathogenesis of coronary heart disease.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2005年第7期716-718,共3页 Chinese Journal of Laboratory Medicine
关键词 丙二酰二醛 低密度脂蛋白 冠心病 血脂 酶联免疫吸附分析 Lipoproteins Low density lipoprotein Cardiovascular diseases
  • 相关文献

参考文献4

  • 1Toshima S, Hasegawa A, Kurabayashi M, et 81. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronaryheart disease. Arterioscler Thromb Vasc Biol , 2000 , 20 : 2243-2247.
  • 2Jessup W, Kritharides L. Metabolism of oxidized LDL by macrophages. Curt Opin Lipidol,2000, 11:473-481.
  • 3Holvoet P , Mertens A , Verhamme P et al . Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease . Arterioscler Thromb Vasc Biol,2001 , 21 : 844-848 .
  • 4Kondo A, Muranaka y, Ohta I, et al . Relationship between triglyceride concentrations and LDL size evaluated by malondialdehyde-modified LDL. Clin Chem , 2001, 47:893-900.

同被引文献23

  • 1Faviou E, Vourli G, Nounopoulos C, et al. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease[J]. Free Radic Res,2005,39(4) :419-429.
  • 2Virella G, Derrick M B, Pate V,et al. Development of capture for different modifications of human low-density lipoprotein [ J ]. Clin Diagn Lab immunol,2005,12 ( 1 ) :68-75.
  • 3Holvoet P, Stassen J M, Van Cleemput J, et al. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease [ J ]. Arterioscler Thromb Vasc Biol, 1998,18 ( 1 ) : 100-107.
  • 4Holvoet P, Perez G, Zhao Z, et al. Malondialdehyde-modified LDL in patients with atherosclerotic disease [ J ]. J Clin Invest, 1995,95 (6) : 2611-2619.
  • 5Ehara S, Ueda M, Naruko T,et al. Elevated levels of oxidized low density lipoprotein show a positive correlation with the severity of acute coronary syndromes [ J ]. Circulation, 2001,103 ( 15 ) : 1955- 1960.
  • 6Wang J J, Liu X Z, Zhuang Y Y, et al. Correlation between susceptibility of LDL subfractions to in vitro oxidation and in vivo oxidized LDL[ J]. Clin Biochem,2000,33 ( 1 ) :71-73.
  • 7Wang J J,Zhuang Y Y,Liu X Z,et al. The in vivo oxidized LDL to LDL-cholesterol ratio is correlated with lipid content of LDL [ J ]. Atherosclerosis,2000,149( 1 ) :217-218.
  • 8Hu B, Wang J J,Zhang C N, et al. Positive correlation between in vivo oxidized LDL and LDL immune complexes [ J ]. Clin Biochem, 2004,37( 1 ) :72-75.
  • 9Wang J J, Qiang H J, Zhang C N, et al. Detection of IgG bound Lp (a) immune complexes in patients with coronary heart disease [ J]. Clin Chim Acta, 2003,327 ( 1-2 ) : 113-122.
  • 10Wang JJ, Qiang HJ, Zhang CN, et al. Detection of IgG bound Lp (a) immune complexes in patients with coronary heart disease [J]. Clin Chim Acta, 2003, 327(1-2) :113-122.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部